Introduction
Sickle cell disease (SCD), an inherited autosomal recessive disorder, results from a single amino acid substitution in the β-chain of hemoglobin (Hbβ s ). Hbβ s polymerizes upon deoxygenation, which distorts the shape of sickle red blood cells (sRBCs). The abnormal RBC shape renders them prone to hemolysis, leading to the release of cell-free hemoglobin and heme in the circulation 1 .
The excess levels of cell-free hemoglobin and heme with their catalytic action on the generation of reactive oxygen species (ROS) contribute to the high oxidative burden in SCD patients 2 , 3 . Neutrophils of SCD patients are activated 4 , and produce significantly higher basal levels of ROS with lower levels of intracellular ROS scavengers 5 . In addition, these neutrophils can capture circulating sRBCs, leading to reduced blood flow in experimental model of vaso-occlusive crises (VOC) induced by the inflammatory cytokine tumor necrosis factor-α (TNF-α) 6 -9 . The altered redox balance likely contributes to SCD pathogenesis One neutrophil response that relies heavily on ROS is the formation of neutrophil extracellular traps (NETs) 11 . NETs are decondensed chromatin decorated by granular enzymes (e.g. neutrophil elastase, NE) and are released by activated neutrophils 1 1
. ROS generation 11 , histone citrullination by peptidylarginine deiminase 4 (PAD4) 18 and transfusion-related acute lung injury (TRALI) 19, 20 .
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In experimentally induced DVT, NET is a part of venous thrombi where it is entangled with platelets and RBCs 21 . In vitro studies using a flow chamber have also shown that NETs can specifically capture platelets and RBCs 1 8 . The ability of NETs to capture intravascular components raises the possibility that neutrophil-derived extracellular DNA fibers could contribute to VOC and the pathogenesis of SCD. We show herein that NETs are generated in SCD from plasma heme and inflammatory cytokines thus linking mechanistically the hemolysis and vaso-occlusive syndromes.
Methods

Human samples
Human blood samples were obtained from healthy non-pregnant adult volunteers, steadystate and crisis SCD patients by protocols approved by the Institutional Review Board.
The study was conducted in accordance with the Declaration of Helsinki. were obtained from Sigma and reconstituted according to the manufacturer's instructions.
Mice
In vitro NET assay
Following isolation, neutrophils were primed with 2ng/ml TNF-α at 37 Abcam) followed by species-specific secondary antibodies coupled with Alexa Fluor Dyes (Invitrogen). DNA was stained using SYTO13. We quantified in vitro NETs by measuring the length of DNA fibers. A DNA fiber was considered as a NET if its length exceeded 50 μm. 
DNase I infusion
SCD mice were intravenously injected (i.v.) with 10mg/kg DNase I at the same time of TNF-α administration.
Heme administration
Hemin was administered by i.p. injection (50μmol/kg body weight) 15 h prior to TNF-α administration. 
Hemopexin infusion
Survival Assay
SCD mice were subjected to cremaster muscle preparation following TNF-α administration as previously described 6, 25 . DNase I (10mg/kg) was i.v. injected to SCD mice immediately before the surgical procedure and hourly post-surgical procedure.
Statistics
All data are represented as mean ± SEM or median (IQR 
Results
NETs are generated in pulmonary microcirculation of SCD mice
To determine if NETs contribute to SCD pathogenesis, we first evaluated whether NETs were generated in SCD mice. We treated SCD mice with TNF-α which can induce experimental VOC 6 -9 . We harvested the lungs of these mice 5 h after TNF-α administration and stained the unfixed lungs with nucleic acid dye Sytox orange for extracellular DNA. Using this technique, we reproducibly detected putative NET DNA fibers in the lungs of SCD mice ( Figure 1A i ). By contrast, such fibers were not observed in the lungs of hemizygous (SA) mice ( Figure 1A ii). To confirm that these elongated DNA fibers were not resulting from section artifacts, we fixed the lung lobes with formalin and stained paraffin-embedded sections with hematoxylin and eosin (H&E).
H&E staining clearly indicated that DNA fibers were present within the pulmonary vessels of SCD mice ( Figure 1B i-ii, arrows) and were absent in SA mice ( Figure 1B iiiiv). To confirm that the network of extracellular DNA fibers was indeed bona fide NETs, and not remnants of apoptotic or necrotic cells, we stained lung tissues with antibodies against NE which has been associated with NETs
and H3Cit, which was shown to be generated specifically during NET formation 2 6 . These analyses revealed areas with robust NE staining (red, Figure 1C i-ii) and H3Cit staining (red, Figure 1C iii-iv) colocalizing with DNA streaks (green, Figure 1C ) within the pulmonary blood vessels of SCD mice. The number of NETs in randomly selected field of view of the immunofluorescence images was significantly greater in TNF-α-stimulated SCD mice compared to PBS-treated SCD or TNF-α-treated SA animals ( Figure 1D and Supplementary Figure 1A ). In addition, we found that soluble NET components such as plasma DNA and nucleosomes were significantly higher in the peripheral blood of TNF-α-stimulated SCD mice ( Figure 1E ). Plasma myeloperoxidase (MPO) activity was also significantly increased in TNF-α-stimulated SCD mice, suggesting that neutrophils in these mice were activated ( Figure 1F ). These data thus indicate that NETs are formed in SCD mice and that they may contribute to the pathogenesis of this disease.
DNase I administration protects SCD mice
To determine if the presence of NETs in SCD mice contributes to the pathogenesis of the disease, we treated mice with DNase I prior to TNF-α administration since in vitro studies have demonstrated that DNase I could dismantle NETs Furthermore, pre-treatment with DNase I protected TNF-α-simulated SCD mice from NET-associated hypothermia ( Figure 2D ). Our previous studies have revealed that TNF-α treatment followed by surgical preparation of the cremaster muscles for intravital microscopy was lethal to SCD mice, but not SA mice, a few hours after the cremasteric
. NET-associated hypothermia of SCD mice was transient as the body temperature of these mice was back to normal 24 h after TNF-α administration (data not shown), which is consistent with our prior observations that TNF-α administration is not sufficient (without surgical insult) to induce a lethal crisis 6 . To investigate whether NET was associated with the rapid death of SCD mice following TNF-α and surgical preparation, we subjected these mice to the cremasteric preparation and TNF-α Both DNase I-and vehicle-infused SCD mice exhibited chronic liver and kidney damage, but there was no major difference in the histopathology of these organs
between the two groups. Our data thus indicate that DNase I treatment specifically alleviates SCD acute lung injury induced by this protocol, and implies that the acute lung injury causes the death of SCD mice.
Sickle cell plasma stimulates NET formation
To gain insight about the mechanism by which NETs are generated in SCD mice,
we tested the capacity of plasma of SCD mice to stimulate NET formation in neutrophils.
We isolated plasma from both SCD and SA mice 5 h after TNF-α administration for an in vitro assay. We found that the addition of SCD plasma to TNF-α-primed wild-type bone marrow (BM) neutrophils led to the generation of a network of extracellular DNA fibers ( Figure 3A , right panel), whereas primed neutrophils treated with SA-derived plasma failed to produce extracellular DNA fibers ( Figure 3A , left panel). Extracellular DNA network formed as a result of SCD plasma stimulation contained H3Cit ( Figure 3B i) and was associated with NE ( Figure 3B ii), suggesting that these DNA fibers were NETs. SCD plasma was able to stimulate TNF-α-primed wild-type BM neutrophils to produce an average of 0.72 ± 0.15 NETs for every 50 cells counted whereas SA plasma was unable to induce NET formation ( Figure 3C and Supplementary Figure 1B and C).
These results suggest that a plasma factor is capable of stimulating neutrophils to produce NETs.
To assess the relevance in human SCD, we compared the DNA concentration, nucleosome content, and MPO activity in the plasma of healthy individuals, SCD patients at steady state or in crisis. Plasma of crisis SCD patients contained significantly higher DNA and nucleosome compared to the other two groups ( Figure 3D 
. In addition, MPO activity was significantly higher in crisis plasma than in nonsickle and steady-state plasma ( Figure 3E) , suggesting an enhanced neutrophil activity that may potentiate increased NET formation in the crisis patients. We next tested the capacity of SCD patient plasma to stimulate NET formation in human peripheral neutrophils. Our results revealed that SCD patient plasma activated neutrophils to produce H3Cit-and NE-positive NETs ( Figure 3F ). In addition, crisis plasma stimulated neutrophils to produce significantly more NETs than those induced by non-sickle and steady-state plasma ( Figure 3G ). These data suggest that the plasma from both mouse and human SCD can trigger NET formation.
Heme induces NET formation in neutrophils in vitro
Plasma of SCD animals has dark brownish color which is consistent with elevated levels of methemalbumin seen in chronic hemolytic disorders ( Figure 4A ) 29 . Elevated heme oxygenase-1 has been reported to inhibit VOC in SCD mouse models 30 , and more recently heme has been suggested to induce acute chest syndrome (ACS) and VOC by activating endothelial cells
. Plasma heme concentrations were higher in TNF-α-treated SCD mice than SA mice ( Figure 4B ). Using an in vitro assay, we found that heme stimulated TNF-α-primed BM neutrophils to generate NETs in a dose-dependent manner ( Figure 4C and 4D i-iii). These DNA fibers could be cleared by addition of DNase I ( Figure 4D iv) and were associated with H3Cit ( Figure 4E i-ii), and NE ( Figure   4E iii-iv). These data thus suggest that heme can induce NET formation in vitro.
For
Heme-induced NET formation is dependent on ROS and heme-iron
Heme can activate blood leukocytes and significantly increase their intracellular ROS concentration 3 3 , 3 4 . Since ROS generation is upstream of NET formation in neutrophils 11 , we hypothesized that heme induces NET formation through upregulation of intracellular ROS. To assess whether heme-mediated NET formation in neutrophils was ROS-dependent, we treated neutrophils with the antioxidant NAC. We found that NAC abrogated heme-stimulated NET formation ( Figure 5A ). Since the redox activities of heme are inhibited by its complexation with hemopexin 35, 36 , we mixed equal molar ratio of heme and hemopexin and simulated neutrophils with the complex. Formation of heme-hemopexin complex was confirmed by the shift in the absorption spectrum from free heme to protein-bound heme by spectrophotometry (data not shown). Addition of hemopexin to heme significantly reduced the number of NETs released by TNF-α-primed neutrophils ( Figure 5B ). By contrast, heme-human serum albumin complex had a slight but not significant reduction in NET formation of primed neutrophils ( Figure 5C ).
Thus, heme-stimulated NET formation in TNF-α-primed neutrophils is dependent on ROS and that complexation of heme with hemopexin inhibits this activity.
Increased hemolysis in SCD can lead to the release of both cell-free hemoglobin and heme
1
. Our in vitro data showed that free heme and serum albumin-bound heme were capable of stimulating NET formation. To evaluate whether the increased cell-free hemoglobin also contributed to NET formation in SCD, we stimulated TNF-α-primed neutrophils with human hemoglobin A 0 (HbA). Unlike heme, we found that equimolar amounts of HbA did not activate primed neutrophils to release NETs ( Figure 5D ). Next, we took advantage of several heme analogs to investigate the structural determinants of Figure 5E ii-iii and Figure 5F ), suggesting iron atom in the porphyrin ring is necessary for heme-mediated NET formation. We also tested the effect of Fe (III) mesoporphryin IX, a heme analog that has iron atom but has two ethyl groups substituted its vinyl groups. Remarkably, primed neutrophils subjected to Fe (III) mesoporphyrin IX stimulation generated significantly more NETs than heme stimulation ( Figure 5E iv and Figure 5F ). These results suggest that heme-mediated NET formation in TNF-α-primed neutrophils depends on the presence of iron atoms.
Heme stimulates NET formation in vivo
Since TNF-α did not induce NETs in SA mice, which do not exhibit pronounced hemolysis (Figure 1) , we reasoned that exogenous addition of heme might be capable of inducing NETs in these animals after TNF-α priming. To investigate this issue, we injected SA mice with heme prior to TNF-α administration. Heme injection significantly increased plasma heme concentration in SA mice compared to vehicle treatment ( Figure   6A ). Increased plasma heme triggered NET formation and resulted in significantly higher number of NETs in the lung ( Figure 6B ). The presence of NETs in pulmonary vessels of SA mice was confirmed with H&E staining of formalin-fixed and paraffinembedded lung sections ( Figure 6C, arrows) , and immunofluorescence analysis which revealed extracellular DNA co-staining with NE (red, Figure 6D i-ii) or H3Cit (red, Figure 6D iii-iv). In agreement with an increase in number of pulmonary NETs, levels of soluble NET components, plasma DNA and nucleosomes, were significantly higher in For personal use only. on April 21, 2017. by guest www.bloodjournal.org From heme-pretreated SA mice compared to vehicle-pretreated animals ( Figure 6E ). Plasma MPO activity was also significantly increased as a result of heme pretreatment, indicating an enhanced neutrophil activity ( Figure 6F ). Furthermore, we observed body temperature reduction following TNF-α administration in heme-pretreated SA mice which were not observed in SA mice not exposed to exogenous heme ( Figure 6G ). We conclude from these experiments that heme is capable of stimulating neutrophils to generate NETs both in vitro and in vivo.
Hemopexin prevents NET formation by reducing plasma heme concentration in SCD mice
Since we found that hemopexin can prevent NETs in vitro ( Figure 5B ), we hypothesized that hemopexin administration could prevent NET formation and may protect SCD mice from NET-associated hypothermia. Hemopexin infusion significantly lowered the plasma heme concentration of SCD mice compared to vehicle-infused animals ( Figure 7A ). Lowered plasma heme levels in SCD mice led to reductions in number of pulmonary NETs and a decrease in plasma DNA and nucleosomes in these mice ( Figure 7B and 7C) . Hemopexin infusion which limited heme availability and prevented heme from stimulating neutrophils, also led to a significant reduction in MPO activity detected in SCD plasma ( Figure 7D ). The reduced neutrophil activation was consistent with reduced NET formation in treated mice. In addition, hemopexin treatment alleviated TNF-α-treated SCD mice from NET-associated hypothermia ( Figure   7E ). These results indicate that, by forming complex with heme and lowering the plasma . Our study adds to the current understanding of heme-mediated SCD pathogenesis by introducing a novel function of heme where we suggest that it can directly activate neutrophils to release NETs which contributes to disease severity.
Our results indicate that proinflammatory cytokine priming is necessary to trigger heme-mediated NET formation with physiological heme concentrations of SCD mice.
Neither TNF-α nor heme alone was sufficient to achieve the stimulation threshold for , and granulocyte colony-stimulating factor (G-CSF) 41 have been shown to potentiate the generation of
NETs. An increase in systemic TNF-α concentration may be associated with infectious episodes, which are important contributing factors for severe complications such as ACS in patients with SCD
.
Our data suggest a model where proinflammatory cytokines predispose neutrophils to be activated by circulating heme which is readily available in SCD individuals. In addition, the present results raise the possibility that NETs play an important role in the pathogenesis of ACS.
The mechanism by which heme stimulates NET formation in neutrophils is currently unknown, but our data suggest that heme-induced NET release could be linked with ROS generation in neutrophils. We have found that the antioxidant NAC abrogated heme-mediated NET release, suggesting heme-elicited ROS increase in neutrophil 33,34 is essential for NET formation. In addition, the requirement for heme-iron in hememediated ROS generation 4 4 and NET production further emphasizes the link between heme-induced oxidative burst and heme-mediated NET formation.
Hemolysis releases cell-free hemoglobin and heme in the circulation in patients with hemoglobinopathies
1
. Cell-free hemoglobin has been shown to contribute to SCD severity by increasing oxidative stress and limiting nitric oxide bioavailability 1 -3
. Our data, however, indicate that heme, but not hemoglobin, can induce NETs in this disease.
Although we have not found a significant effect of hemopexin administration on survival of SCD mice, our dosages failed to reduce plasma concentration of heme
following TNF-α administration and surgical trauma. However, DNase I treatment did prolong the survival of SCD mice which indicates that NETs contribute to the rapid death of SCD mice following TNF-α administration and surgical trauma. BAL and histological evaluation of SCD lungs have revealed evidence of increased vascular permeability, inflammation, and thickened alveolar walls following this VOC protocol. DNase I treatment improved these abnormalities, suggesting that the fibrillar appearance and capillary wall damage may be due to localized high concentration of exposed histones and NET-derived granular enzymes. Liberated histones can indeed induce platelet activation and aggregation 18, 45 and also promote neutrophil margination and accumulation in alveolar microvessels 46 . Our data are thus consistent with the possibility that NETs inflict damage on endothelial cells, promoting accumulation of blood cells in pulmonary vessels resulting in impaired flow and gas exchanges, and thus contributing to rapid death of these mice.
In summary, our results indicate that NETs are formed and likely pathogenic in SCD. Our findings, supported by a recent report of circulating nucleosomes in SCD patients admitted for VOC or ACS 4 7 , highlight a crucial role for heme in inducing NET formation in neutrophils following proinflammatory cytokine priming. The association of short alleles of the heme oxygenase-1 promoter (associated with higher enzyme activity) with lower rates of hospitalization for ACS 48 also supports our findings that NETs are generated in the pulmonary vasculature in SCD. Managing the amount of circulating heme in SCD individuals such as increasing their plasma hemopexin may therefore be a useful strategy to prevent NET-inflicted damages.
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FIGURE 3
Plasma from TNF-α-stimulated SCD mice and crisis SCD patients induce NET formation in TNF-α-primed neutrophils. Insets show NETs stained with DNA dye (green/SYTO13) and isotype control antibodies for H3Cit and NE. Scale bar, 10 μm.
(G) Quantification of NETs released by TNF-α-primed human neutrophils stimulated with plasma of non-SCD individuals (grey circle, n=3), steady-state SCD patients (yellow circle, n=7), and crisis SCD patients (red circle, n=8; mean ± SEM, *p<0.05, **p<0.01).
FIGURE 4
Heme stimulates NET formation in neutrophils in vitro.
(A) Representative images of plasma of TNF-α-stimulated SCD mice and SA mice.
(B) Quantification of plasma heme concentrations of TNF-α-stimulated SA mice (black circle, n=8), TNF-α-stimulated SCD mice (white circle, n=5), and PBS-treated SCD mice (gray circle, n=6; mean ± SEM, ***p<0.001).
